Skip to main content
. 2000 Aug;38(8):2998–3003. doi: 10.1128/jcm.38.8.2998-3003.2000

TABLE 3.

Correlation between reactivity in the immunoblot and quantitative CP5 expression measured by ELISA inhibition

Expt no. and S. aureus strain Source Immunoblot reactivitya Amt (μg) of CP5/1010 CFU % of control
1
 Reynolds (control) Human 4+ 518 100
 PS15rr (U.S.) Bovine 4+ 518 100
 AA405 (U.S.) Bovine 4+ 411 79
 Myco 15 (U.S.) Bovine 4+ 278 54
2
 Reynolds (control) Human 4+ 2,400 100
 PS Milk (U.S.) Bovine 2–3+ 209 8.7
 Gutz 5 (U.S.) Bovine 2+ 91 3.8
 3263 (U.S.) Bovine 2+ 42 1.8
 KK 13 (U.S.) Bovine 1+ 52 2.2
3
 Reynolds (control) Human 4+ 1,984 100
 AA26 (U.S.) Bovine 2–3+ 120 6.0
 WSU 1 (U.S.) Bovine 2+ 64 3.2
 Myco 11 (U.S.) Bovine 2+ 13 0.7
 Hook 14 (U.S.) Bovine 1–2+ 13 0.7
4
 7125-2 (control)  (Sweden) Bovine 4+ 1,177 100
 6698-1 (Sweden) Bovine ± 4 0.3
 55-46 (Finland) Bovine ± 4 0.3
 78-9 (Finland) Bovine ± 16 1.4
 2076 (Iceland) Bovine ± 6 0.5
a

1+, very weak; 2+, medium; 3+, strong; 4+, very strong; ±, little to none.